(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENESIGHT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENESIGHT

ST13

US500000098653348

Class

5, 42, 44

Filing

98653348

Registration

7912058

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

05/29/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

07/17/2024

Registration date

08/26/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/26/2025

Last transaction

05/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

03/11/2013

First use in commerce

03/11/2013

Drawing code

4

Owner type

03

Owner location

Salt Lake City, UT, US

Examiner

BRENNER, BRANDI M

Law office

O10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Myriad Genetics, Inc.

Representatives

Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical specimen collection kits comprised primarily of swabs for collecting DNA and also including printed instructionsenvelopes and printed mailing materials for transmitting biological specimens of patients for the purpose of determining medication efficacy; Medical specimen collection kits comprised primarily of swabs for collecting DNA and also including printed instructionsenvelopes and printed mailing materials for transmitting specimens for the purpose of analyzing and interpreting genes of patients to predict which drugs have the best opportunity for positive outcomes for patientspersonalize medication selection and treatment choices for patientscalculate drug dosage adjustments for patientsidentify potentially harmful interactions between genes and drugs; Medical specimen collection kits comprised primarily of swabs for collecting DNA and also including printed instructionsenvelopes and printed mailing materials for genetic and genomic testing related to psychiatry

Class 42

Providing temporary use of non-downloadable computer software for customizingselectingordering health and genetic analysis and testing kits and for accessingviewingstoring health and genetic information via electronicopticalwireless communication networks

Class 44

Genetic testing for medical purposes; genetic counseling; providing medical information in the field of psychotropic assessment and testing; providing an internet website featuring medical information in the field of psychotropic assessment and testing; predictive medical analysis services relating to the selection of treatments for psychiatric conditions

Publications

History of USPTO decisions and trademark events.

20 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/26/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/26/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/26/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/26/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/26/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/26/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/26/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/08/2025

PUBO

PUBLISHED FOR OPPOSITION

07/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/06/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/06/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/10/2025

GNRT

NON-FINAL ACTION E-MAILED

02/10/2025

CNRT

NON-FINAL ACTION WRITTEN

02/10/2025

DOCK

ASSIGNED TO EXAMINER

01/28/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/15/2025

NWAP

NEW APPLICATION ENTERED

07/17/2024

Continuous trademark protection

Get notified about every new filing that threatens GENESIGHT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.